Bolt Biotherapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:BOLT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -13.37 M-9.6 M-9.73 M-7.16 M-8.02 M-6.54 M -31.45 M Cash from investing activities 14.55 M10.79 M17.88 M1.07 M7.92 M7.77 M 34.65 M Cash from financing activities 014 K05 0006 00019 K 30 K Free cash flow -13.37 M-9.6 M-9.8 M-7.16 M-8.02 M-6.54 M -31.52 M

News

Ryan Breslow is raising up to $27M in pay-to-play bridge funding to save Bolt

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Misses Revenue Estimates

Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates

Repligen (RGEN) Beats Q2 Earnings and Revenue Estimates

Lightning Labs Announces Wavelength: Offers Developers and AI Agents 'Bitcoin Easy Mode'

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright